Shanghai Runda Medical Technology (603108.SS) Earnings Analysis
Shanghai Runda Medical Technology (603108.SS) has no confirmed upcoming earnings date. Trailing P/E -10.38.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 603108.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 603108.SS. This page updates as the calendar is published.
603108.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-10-29 | -0.06964 CNY | n/a | n/a | n/a |
| 2025-04-25 | -0.11 CNY | n/a | n/a | n/a |
| 2024-12-31 | 0.00781 CNY | n/a | n/a | n/a |
| 2024-08-28 | 0.1147 CNY | n/a | n/a | n/a |
603108.SS valuation and analyst view
| Trailing P/E | -10.38 |
|---|---|
| Trailing EPS | -0.88238 CNY |
| Price / book | 1.51 |
| Dividend yield | 0.33% |
| Market cap | 5.58B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shanghai Runda Medical Technology (603108.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 603108.SS. This page updates as the calendar is published.
Did 603108.SS beat earnings last quarter?
Consensus estimate data was not available for 603108.SS's 2025-10-29 report.
What is 603108.SS's current P/E ratio and EPS?
603108.SS trades at a trailing P/E of -10.38 on trailing EPS of -0.8823811843042293 CNY.
What do analysts rate 603108.SS?
603108.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.